Skip to content

Influence of wearing glasses to filter blue light in the nighttime period on the perception of sleep quality and clinical parameters of critically ill patients

Influence the blue light filter in the nighttime period on the perception of sleep quality and clinical parameters of critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3snw7t
Enrollment
Unknown
Registered
2019-10-24
Start date
2019-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardium infarction

Interventions

Experimental group: 50 patients admitted to intensive care will use glasses with filter for blue light, therefore, in wavelength between 380 and 460 nanometers, and lateral blockage for light passage
Device
J01.637.708.560.500

Sponsors

Escola Paulista de Enfermagem da Universidade Federal de São Paulo
Lead Sponsor
Escola Paulista de Enfermagem da Universidade Federal de São Paulo
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: The sample will be composed of patients older than 18 years; who suffered a primary event of acute myocardial infarction with or without supra-level ST tracking; hospitalized to an intensive care unit; with a minimum score of 14 points in the Glasgow Coma Scale; with a stay of at least 12 hours in the unit, without cognitive impairment; in spontaneous ventilation or using noninvasive ventilatory support

Exclusion criteria

Exclusion criteria: Blind patients of the quiasmatic type will be excluded. Also excluded are patients who are in Killip IV; sedata; inpatient women without the use of delayed bladder catheterization; inincontinent men without the use of delayed bladder catheterization and who do not adapt to the use of a non-invasive device for urine collection (Uripen®); patients who have predictors related to sleep apnea such as: Body Mass Index (BMI) greater than 35; Score greater than 10 on the Epworth daytime sleepiness rating scale; Snoring; witnessed apneas; wheezing that suffocates the night; unfavorable clinical outcome (hemodynamic and respiratory instability); confirmed diagnosis of sleep apnea and patients who were discharged during data collection

Design outcomes

Primary

MeasureTime frame
To verify the improvement of sleep quality parameters through analysis of the variables related to sleep (Activity and rest evaluation by actigraphy; Questionnaire for assessing the quality of sleep in the cardiological ICU; Chronotype Questionnaire Morningness- Eveningness Questionnaire (MEQ) by Horne & Östberg). The data will be analyzed using: mean, median, standard deviation, paired T-Test and analysis of variance (ANOVA),Considering significant p values less than or equal to 0.05.;To verify the improvement of pain reports by pain score through the numerical verbal pain scale (0-10).

Secondary

MeasureTime frame
Evaluation of the perception of daytime sleepiness after the use of glasses with blue light block in the night period,Through the Epworth scale and evaluation of sleep quality in the last month through the Pittsburgh Sleep Quality Index Questionnaire PSQI). The data will be analyzed using: mean, median, standard deviation, paired T-Test and analysis of variance (ANOVA),Considering significant p values less than or equal to 0.05.;Evaluate the excretion level of the urinary melatonin metabolite. Laboratory analysis of the level of 6-sulfatoximelatonin in the urine will be performed using the ELISA method, from the evaluation by the Spectrophotometer.The quantification of the samples will be performed by interpolating the values in a standard curve.The data will be analyzed using: mean, median, standard deviation, paired T-Test and analysis of variance (ANOVA),Considering significant p values less than or equal to 0.05.

Countries

Brazil

Contacts

Public ContactAriane Avelar

Escola Paulista de Enfermagem

ariane.machado@unifesp.br+55(11)983526567

Outcome results

None listed

Source: REBEC (via WHO ICTRP)